Annual Operating Expenses
$50.36 M
+$8.71 M+20.91%
31 December 2023
Summary:
Compass Therapeutics annual total operating expenses is currently $50.36 million, with the most recent change of +$8.71 million (+20.91%) on 31 December 2023. During the last 3 years, it has risen by +$22.55 million (+81.08%). CMPX annual operating expenses is now at all-time high.CMPX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$12.24 M
-$3.66 M-23.00%
01 September 2024
Summary:
Compass Therapeutics quarterly total operating expenses is currently $12.24 million, with the most recent change of -$3.66 million (-23.00%) on 01 September 2024. Over the past year, it has increased by +$313.00 thousand (+2.62%). CMPX quarterly operating expenses is now -23.00% below its all-time high of $15.89 million, reached on 01 June 2024.CMPX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMPX Operating Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +20.9% | +2.6% |
3 y3 years | +81.1% | +109.1% |
5 y5 years | +31.4% | +46.0% |
CMPX Operating Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +81.1% | -23.0% | +109.1% |
5 y | 5 years | at high | +81.1% | -23.0% | +141.4% |
alltime | all time | at high | +81.1% | -23.0% | +141.4% |
Compass Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $12.24 M(-23.0%) |
June 2024 | - | $15.89 M(+24.5%) |
Mar 2024 | - | $12.77 M(-17.0%) |
Dec 2023 | $50.36 M(+20.9%) | $15.39 M(+29.1%) |
Sept 2023 | - | $11.93 M(-10.6%) |
June 2023 | - | $13.34 M(+37.3%) |
Mar 2023 | - | $9.71 M(-24.7%) |
Dec 2022 | $41.66 M(+33.2%) | $12.89 M(+2.3%) |
Sept 2022 | - | $12.60 M(+40.2%) |
June 2022 | - | $8.99 M(+25.1%) |
Mar 2022 | - | $7.18 M(-44.8%) |
Dec 2021 | $31.26 M | - |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | - | $13.00 M(+122.1%) |
Sept 2021 | - | $5.85 M(+15.4%) |
June 2021 | - | $5.07 M(-30.9%) |
Mar 2021 | - | $7.34 M(-7.7%) |
Dec 2020 | $27.81 M(-18.3%) | $7.95 M(-11.3%) |
Sept 2020 | - | $8.96 M(+76.7%) |
June 2020 | - | $5.07 M(-13.1%) |
Mar 2020 | - | $5.83 M(-8.9%) |
Dec 2019 | $34.05 M(-11.1%) | $6.40 M(-23.6%) |
Sept 2019 | - | $8.38 M(-3.3%) |
June 2019 | - | $8.67 M |
Dec 2018 | $38.31 M | - |
FAQ
- What is Compass Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Compass Therapeutics?
- What is Compass Therapeutics annual operating expenses year-on-year change?
- What is Compass Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Compass Therapeutics?
- What is Compass Therapeutics quarterly operating expenses year-on-year change?
What is Compass Therapeutics annual total operating expenses?
The current annual operating expenses of CMPX is $50.36 M
What is the all time high annual operating expenses for Compass Therapeutics?
Compass Therapeutics all-time high annual total operating expenses is $50.36 M
What is Compass Therapeutics annual operating expenses year-on-year change?
Over the past year, CMPX annual total operating expenses has changed by +$8.71 M (+20.91%)
What is Compass Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of CMPX is $12.24 M
What is the all time high quarterly operating expenses for Compass Therapeutics?
Compass Therapeutics all-time high quarterly total operating expenses is $15.89 M
What is Compass Therapeutics quarterly operating expenses year-on-year change?
Over the past year, CMPX quarterly total operating expenses has changed by +$313.00 K (+2.62%)